Home Cart 0 Sign in  

[ CAS No. 50-33-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 50-33-9
Chemical Structure| 50-33-9
Structure of 50-33-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 50-33-9 ]

Related Doc. of [ 50-33-9 ]

Alternatived Products of [ 50-33-9 ]

Product Details of [ 50-33-9 ]

CAS No. :50-33-9 MDL No. :MFCD00005500
Formula : C19H20N2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :VYMDGNCVAMGZFE-UHFFFAOYSA-N
M.W : 308.37 Pubchem ID :4781
Synonyms :
Butazolidine

Calculated chemistry of [ 50-33-9 ]

Physicochemical Properties

Num. heavy atoms : 23
Num. arom. heavy atoms : 12
Fraction Csp3 : 0.26
Num. rotatable bonds : 5
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 97.76
TPSA : 40.62 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -5.94 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.32
Log Po/w (XLOGP3) : 3.16
Log Po/w (WLOGP) : 3.03
Log Po/w (MLOGP) : 3.51
Log Po/w (SILICOS-IT) : 2.89
Consensus Log Po/w : 3.18

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.8
Solubility : 0.049 mg/ml ; 0.000159 mol/l
Class : Soluble
Log S (Ali) : -3.68
Solubility : 0.0639 mg/ml ; 0.000207 mol/l
Class : Soluble
Log S (SILICOS-IT) : -5.55
Solubility : 0.000867 mg/ml ; 0.00000281 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 1.0 alert
Brenk : 1.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 3.12

Safety of [ 50-33-9 ]

Signal Word:Danger Class:6.1
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P310+P330-P405 UN#:2811
Hazard Statements:H301-H315-H319 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 50-33-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 50-33-9 ]
  • Downstream synthetic route of [ 50-33-9 ]

[ 50-33-9 ] Synthesis Path-Upstream   1~14

  • 1
  • [ 109-65-9 ]
  • [ 2652-77-9 ]
  • [ 50-33-9 ]
Reference: [1] Journal of Labelled Compounds and Radiopharmaceuticals, 2018, vol. 61, # 4, p. 386 - 390
[2] Patent: US2562830, 1949, ,
[3] DRP/DRBP Org.Chem.,
  • 2
  • [ 109-65-9 ]
  • [ 2652-77-9 ]
  • [ 50-33-9 ]
  • [ 102886-57-7 ]
Reference: [1] Journal of Labelled Compounds and Radiopharmaceuticals, 2018, vol. 61, # 4, p. 386 - 390
  • 3
  • [ 23111-33-3 ]
  • [ 50-33-9 ]
Reference: [1] Journal of Pharmaceutical Sciences, 2010, vol. 99, # 6, p. 2711 - 2723
[2] Journal of Pharmaceutical Sciences, 2010, vol. 99, # 6, p. 2711 - 2723
  • 4
  • [ 1229645-19-5 ]
  • [ 50-33-9 ]
Reference: [1] Journal of Pharmaceutical Sciences, 2010, vol. 99, # 6, p. 2711 - 2723
  • 5
  • [ 1229521-07-6 ]
  • [ 50-33-9 ]
Reference: [1] Journal of Pharmaceutical Sciences, 2010, vol. 99, # 6, p. 2711 - 2723
  • 6
  • [ 1229521-08-7 ]
  • [ 50-33-9 ]
Reference: [1] Journal of Pharmaceutical Sciences, 2010, vol. 99, # 6, p. 2711 - 2723
  • 7
  • [ 1229645-20-8 ]
  • [ 50-33-9 ]
Reference: [1] Journal of Pharmaceutical Sciences, 2010, vol. 99, # 6, p. 2711 - 2723
  • 8
  • [ 122-66-7 ]
  • [ 50-33-9 ]
Reference: [1] Journal of Labelled Compounds and Radiopharmaceuticals, 2018, vol. 61, # 4, p. 386 - 390
  • 9
  • [ 133-08-4 ]
  • [ 122-66-7 ]
  • [ 50-33-9 ]
Reference: [1] Zhurnal Obshchei Khimii, 1958, vol. 28, p. 2355,2358; engl. Ausg. S. 2393, 2395
[2] Patent: US2562830, 1949, ,
[3] DRP/DRBP Org.Chem.,
  • 10
  • [ 133-08-4 ]
  • [ 22293-38-5 ]
  • [ 50-33-9 ]
Reference: [1] Patent: US2562830, 1949, ,
[2] DRP/DRBP Org.Chem.,
  • 11
  • [ 122-66-7 ]
  • [ 17999-54-1 ]
  • [ 50-33-9 ]
Reference: [1] Patent: US2562830, 1949, ,
[2] DRP/DRBP Org.Chem.,
  • 12
  • [ 534-59-8 ]
  • [ 50-33-9 ]
Reference: [1] Journal of the Indian Chemical Society, 1953, vol. 30, p. 841,842
  • 13
  • [ 2652-77-9 ]
  • [ 71-36-3 ]
  • [ 50-33-9 ]
Reference: [1] Experientia, 1959, vol. 15, p. 95
  • 14
  • [ 122-66-7 ]
  • [ 50-33-9 ]
Reference: [1] Journal of the Indian Chemical Society, 1953, vol. 30, p. 841,842
Same Skeleton Products
Historical Records

Similar Product of
[ 50-33-9 ]

Chemical Structure| 1325559-13-4

A1256317[ 1325559-13-4 ]

4-Butyl-1,2-di(phenyl-13C6)pyrazolidine-3,5-dione

Reason: Stable Isotope

Chemical Structure| 129-18-0

A138693[ 129-18-0 ]

Sodium 4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-ide

Reason: Free-salt

Related Functional Groups of
[ 50-33-9 ]

Aryls

Chemical Structure| 129-18-0

[ 129-18-0 ]

Sodium 4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-ide

Similarity: 0.99

Chemical Structure| 92-43-3

[ 92-43-3 ]

1-Phenyl-3-pyrazolidinone

Similarity: 0.81

Chemical Structure| 1251-85-0

[ 1251-85-0 ]

4,4'-Methylenebis(1,5-dimethyl-2-phenyl-1H-pyrazol-3(2H)-one)

Similarity: 0.72

Chemical Structure| 56430-08-1

[ 56430-08-1 ]

1,5-Dimethyl-2-(p-tolyl)-1H-pyrazol-3(2H)-one

Similarity: 0.68

Chemical Structure| 277299-70-4

[ 277299-70-4 ]

2-(3,4-Dimethylphenyl)-5-methyl-1H-pyrazol-3(2H)-one

Similarity: 0.68

Amides

Chemical Structure| 129-18-0

[ 129-18-0 ]

Sodium 4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-ide

Similarity: 0.99

Chemical Structure| 92-43-3

[ 92-43-3 ]

1-Phenyl-3-pyrazolidinone

Similarity: 0.81

Chemical Structure| 1251-85-0

[ 1251-85-0 ]

4,4'-Methylenebis(1,5-dimethyl-2-phenyl-1H-pyrazol-3(2H)-one)

Similarity: 0.72

Chemical Structure| 56430-08-1

[ 56430-08-1 ]

1,5-Dimethyl-2-(p-tolyl)-1H-pyrazol-3(2H)-one

Similarity: 0.68

Chemical Structure| 277299-70-4

[ 277299-70-4 ]

2-(3,4-Dimethylphenyl)-5-methyl-1H-pyrazol-3(2H)-one

Similarity: 0.68

Related Parent Nucleus of
[ 50-33-9 ]

Pyrazoles

Chemical Structure| 129-18-0

[ 129-18-0 ]

Sodium 4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-ide

Similarity: 0.99

Chemical Structure| 92-43-3

[ 92-43-3 ]

1-Phenyl-3-pyrazolidinone

Similarity: 0.81

Chemical Structure| 1251-85-0

[ 1251-85-0 ]

4,4'-Methylenebis(1,5-dimethyl-2-phenyl-1H-pyrazol-3(2H)-one)

Similarity: 0.72

Chemical Structure| 56430-08-1

[ 56430-08-1 ]

1,5-Dimethyl-2-(p-tolyl)-1H-pyrazol-3(2H)-one

Similarity: 0.68

Chemical Structure| 277299-70-4

[ 277299-70-4 ]

2-(3,4-Dimethylphenyl)-5-methyl-1H-pyrazol-3(2H)-one

Similarity: 0.68